Avidity Biosciences (RNA) Stock Chart & Stock Price History → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free RNA Stock Alerts $24.36 +0.53 (+2.22%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial Media Avidity Biosciences Stock Price Performance5 Day Performance+7.17%1 Month Performance+1.29%3 Month Performance+102.33%6 Month Performance+361.36%Year-To-Date Performance+169.17%1 Year Performance+40.48% Receive RNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. RNA Stock Chart for Friday, April, 26, 2024 RNA Chart by TradingView Avidity Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$23.83$24.36+2.22%$24.76$23.491.03 million shs$1.94 billion04/25/2024$25.09$23.83-5.02%$24.96$23.351.24 million shs$1.90 billion04/24/2024$25.14$25.09-0.20%$25.82$24.74559,786 shs$2.00 billion04/23/2024$24.16$25.14+4.06%$26.02$24.06859,065 shs$2.00 billion04/22/2024$22.73$24.16+6.29%$24.83$22.75911,772 shs$1.93 billion04/19/2024$23.04$22.73-1.35%$23.59$22.241.01 million shs$1.81 billion Get the Latest News and Ratings for RNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$23.55$23.04-2.17%$23.98$22.781.14 million shs$1.84 billion04/17/2024$23.91$23.55-1.51%$24.24$23.43716,621 shs$1.88 billion04/16/2024$23.91$23.91$24.20$23.25715,731 shs$1.91 billion04/15/2024$24.09$23.91-0.75%$24.44$23.62866,954 shs$1.91 billion04/12/2024$25.35$24.09-4.97%$25.50$23.91798,506 shs$1.92 billion04/11/2024$25.64$25.35-1.13%$25.99$25.19724,496 shs$2.02 billion04/10/2024$25.86$25.64-0.85%$25.80$24.451.04 million shs$2.04 billion04/09/2024$24.78$25.86+4.36%$25.86$24.51501,552 shs$2.06 billion04/08/2024$24.63$24.78+0.61%$25.24$24.00539,450 shs$1.98 billion04/05/2024$23.69$24.63+3.97%$24.75$22.94976,601 shs$1.96 billion04/04/2024$26.64$23.69-11.07%$27.17$21.562.59 million shs$1.89 billion04/03/2024$26.87$26.64-0.86%$27.66$26.09949,862 shs$2.12 billion04/02/2024$26.40$26.87+1.78%$26.98$25.091.31 million shs$2.14 billion04/01/2024$25.52$26.40+3.45%$26.62$24.78930,460 shs$2.10 billion03/29/2024$25.52$25.52$25.95$24.501.23 million shs$2.03 billion03/28/2024$24.67$25.52+3.45%$25.85$24.511.23 million shs$2.03 billion03/27/2024$24.05$24.67+2.58%$25.61$23.701.85 million shs$1.97 billion03/26/2024$23.19$24.05+3.71%$24.39$23.50976,829 shs$1.92 billion03/25/2024$23.70$23.19-2.15%$24.20$22.851.10 million shs$1.85 billion03/22/2024$24.10$23.70-1.66%$24.61$23.47738,658 shs$1.89 billion03/21/2024$24.24$24.10-0.58%$24.83$23.781.08 million shs$1.92 billion03/20/2024$23.79$24.24+1.89%$24.81$23.451.29 million shs$1.93 billion03/19/2024$23.93$23.79-0.59%$24.70$23.201.34 million shs$1.90 billion03/18/2024$24.42$23.93-2.01%$25.12$23.661.98 million shs$1.91 billion03/15/2024$23.97$24.42+1.88%$24.94$23.731.68 million shs$1.95 billion03/14/2024$24.83$23.97-3.46%$26.24$23.502.39 million shs$1.91 billion03/13/2024$22.69$24.83+9.43%$24.91$22.251.49 million shs$1.98 billion03/12/2024$21.02$22.69+7.94%$22.78$20.911.22 million shs$1.81 billion03/11/2024$21.46$21.02-2.05%$21.67$20.801.03 million shs$1.68 billion03/08/2024$20.02$21.46+7.19%$21.55$20.341.33 million shs$1.71 billion03/07/2024$20.02$20.02$20.73$19.241.97 million shs$1.60 billion03/06/2024$19.14$20.02+4.60%$20.61$19.181.45 million shs$1.60 billion03/05/2024$18.86$19.14+1.48%$19.87$18.561.31 million shs$1.53 billion03/04/2024$20.11$18.86-6.22%$20.63$16.303.93 million shs$1.51 billionMove Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately.03/01/2024$18.30$20.11+9.89%$20.35$18.382.43 million shs$1.49 billion02/29/2024$15.26$18.30+19.92%$19.46$17.713.96 million shs$1.36 billion02/28/2024$15.31$15.26-0.33%$15.78$14.75841,361 shs$1.13 billion02/27/2024$14.51$15.31+5.51%$15.67$14.561.44 million shs$1.13 billion02/26/2024$14.04$14.51+3.35%$14.95$14.10587,002 shs$1.08 billion02/23/2024$14.54$14.04-3.44%$14.57$13.73501,535 shs$1.04 billion02/22/2024$14.39$14.54+1.04%$14.97$14.30547,250 shs$1.08 billion02/21/2024$13.98$14.39+2.93%$14.44$13.68730,555 shs$1.07 billion02/20/2024$14.18$13.98-1.41%$14.61$13.79526,222 shs$1.04 billion02/19/2024$14.18$14.18$14.38$13.21810,400 shs$1.05 billion02/16/2024$13.53$14.18+4.80%$14.34$13.21810,489 shs$1.05 billion02/15/2024$13.51$13.53+0.15%$14.16$13.481.04 million shs$1.00 billion02/14/2024$13.27$13.51+1.81%$13.90$13.17683,294 shs$1.00 billion02/13/2024$14.54$13.27-8.73%$14.13$13.011.05 million shs$983.31 million02/12/2024$13.35$14.54+8.91%$14.71$13.341.11 million shs$1.08 billion02/09/2024$12.51$13.35+6.71%$13.51$12.52678,618 shs$989.24 million02/08/2024$12.14$12.51+3.05%$12.74$12.02606,024 shs$926.99 million02/07/2024$12.32$12.14-1.46%$12.39$12.13448,861 shs$899.57 million02/06/2024$11.64$12.32+5.84%$12.33$11.50560,590 shs$912.92 million02/05/2024$11.63$11.64+0.09%$11.77$11.23589,714 shs$862.52 million02/02/2024$12.14$11.63-4.20%$12.20$11.531.21 million shs$861.78 million02/01/2024$12.23$12.14-0.74%$12.42$11.62861,896 shs$899.59 million01/31/2024$11.80$12.23+3.64%$12.79$11.80741,736 shs$906.24 million01/30/2024$12.61$11.80-6.42%$12.60$11.79627,188 shs$874.38 million01/29/2024$12.04$12.61+4.73%$13.05$11.511.53 million shs$934.40 million01/26/2024$10.47$12.04+15.00%$12.55$10.303.91 million shs$892.16 million01/25/2024$10.16$10.47+3.05%$10.71$10.27661,804 shs$775.83 million Related Companies: PTC Therapeutics Stock Chart Galapagos Stock Chart Geron Stock Chart Amphastar Pharmaceuticals Stock Chart Catalyst Pharmaceuticals Stock Chart Syndax Pharmaceuticals Stock Chart Schrödinger Stock Chart Maravai LifeSciences Stock Chart Structure Therapeutics Stock Chart NewAmsterdam Pharma Stock Chart Receive RNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.